Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Evaluating muscle oxygenation in COPD patients during respiratory fatigue

Official title: Examining the Relationship Between Respiratory Muscle Fatigue and Lower Extremity Muscle Oxygenation in Chronic Obstructive Pulmonary Disease Patients.

Run by Istanbul Medipol University Hospital · NCT06217276 · Data updated 2026-11-12

This study is testing how muscle oxygen levels change in people with COPD during breathing fatigue to see how it compares to healthy individuals.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorIstanbul Medipol University Hospital
Academic / other
Locations1 site (Istanbul, Zeytinburnu)
StatusRecruiting
StartedJanuary 20, 2024
Main results expectedJanuary 15, 2026
Study endsJanuary 15, 2026
Registry record updatedMay 1, 2025
Trial IDNCT06217276 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Stage 2-3 COPD who have been stable on their medications for at least four weeks.

Probably not a fit

Patients with severe comorbidities, recent acute COPD exacerbations, or other significant respiratory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates changes in oxygenation levels of the vastus lateralis muscle in patients with Stage 2-3 COPD using the Moxy device, which measures functional infrared oxygen levels. Participants will undergo a respiratory muscle fatigue protocol to assess how their muscle oxygenation responds compared to healthy controls. The study aims to provide insights into the relationship between respiratory muscle fatigue and lower extremity muscle oxygenation in COPD patients.

Why it matters

Potential benefit: If successful, this study could enhance understanding of muscle oxygenation in COPD, potentially leading to improved management strategies for patients.

How similar studies have gone: While the specific approach of this study may be novel, similar studies have explored muscle oxygenation in respiratory conditions, indicating potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Having a diagnosis of Stage 2-3 COPD according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
* Having been using the same medications for the last 4 weeks

Exclusion Criteria:

* Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min).
* Presence of any vascular problem that may affect lower extremity muscle oxygenation
* Presence of another respiratory system disease other than COPD
* Patients who have had an acute COPD exacerbation in the last 4 weeks
* Patients experiencing COPD exacerbations during the study protocol
* Presence of fatty tissue or scar tissue at the measurement points, which may impair the measurement quality.
* Have already participated in another clinical trial within the last 30 days that may affect the results of the study.

Inclusion Criteria for Healthy Cases

* Being over 18 years of age
* Not having any diagnosed chronic disease
* Not being a smoker

Where it's running

  • Yedikule Chest Disease Hospital
    Istanbul, Zeytinburnu, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

    This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

    Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

  • Cognitive load and inhaler technique in COPD

    This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

    Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

  • Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

    A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

    Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

  • Continuous vs High-Intensity Interval Exercise in COPD

    This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

    Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

  • Biomarker clues for COPD, IPF, and lung cancer

    This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

    Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

  • HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

    This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

    Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.